EP3898668
Mótefni sem hlutleysa lifrarbólgu B veiru og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.12.2019EP published:
30.8.2023EP application number:
19839558.4
EP translation filed:
13.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
17.12.2039Expiry date:
17.12.2026Next due date:
31.12.2026
Title in English:
ANTIBODIES THAT NEUTRALIZE HEPATITIS B VIRUS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
18.12.2019EP application
30.8.2023EP Publication
13.11.2023Translation submitted
15.12.2023Registration published
17.12.2026Expires
Owner
Name:
Humabs Biomed SAAddress:
Via dei Gaggini, 3, 6500 Bellinzona, CH
Inventor
Name:
CORTI, DavideAddress:
6500 Bellinzona, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862782274 PDate:
19.12.2018Country:
US
Number:
201962860085 PDate:
11.6.2019Country:
US
Classification
Categories:
C07K 16/08, C07K 16/10, A61K 31/522, A61K 39/395, A61P 31/14, A61P 31/20
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 15.12.2023
Expires: 17.12.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 10.12.2024
Expires: 17.12.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 15.12.2025
Expires: 17.12.2026
Payer: Árnason Faktor ehf.